- Clinical Hematology & Oncology 2024
- Melanoma 2024: 34th Annual Cutaneous Malignancy Update
- 2023 Cancer Care Symposium
- 2023 Oncology Update
- Clinical Hematology & Oncology 2023
- Melanoma 2023: 33rd Annual Cutaneous Malignancy Update
- 2022 Cancer Care Symposium
- Clinical Hematology & Oncology 2022
- Melanoma 2022: 32nd Annual Cutaneous Malignancy Update
- 2021 Cancer Care Symposium
- Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
- Eighth Annual Scripps Cancer Care Symposium
- Melanoma 2020: 30th Annual Cutaneous Malignancy Update
- 7th Annual Scripps Cancer Care Symposium
- 2019 Oncology Update
- Melanoma 2019: 29th Annual Cutaneous Malignancy Update
- Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
- Videos
- Events
Playback speed
10 seconds
CLL Practice Changing Studies From ASCO 2019: Acalabrutinib + Obinutuzumab in R/R, Superiority of Venetoclax/obinutuzumab in Elderly Patients & Comparing Frontline Options
By
2019 Scripps MD Anderson's Oncology Update
FEATURING
Alan Saven
By
2019 Scripps MD Anderson's Oncology Update
FEATURING
Alan Saven
510 views
August 19, 2019
Login to view comments.
Click here to Login
2019 Oncology Update Videos